NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zymeworks Inc (NYSE: ZYME)

 
ZYME Technical Analysis
5
As on 18th May 2022 ZYME Share Price closed @ 5.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 35.70 & Strong Sell for SHORT-TERM with Stoploss of 48.22 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZYME Share Price

Open 5.75 Change Price %
High 5.84 1 Day -0.71 -12.07
Low 5.10 1 Week -0.27 -4.96
Close 5.17 1 Month -1.49 -22.37
Volume 1421833 1 Year -49.61 -90.56
52 Week High 56.81 | 52 Week Low 4.82
 
NYSE USA Most Active Stocks
DDR 15.44 -4.46%
BACA-U 302.00 0.67%
NIO 15.83 -4.81%
F 12.78 -5.54%
NLY 6.36 -1.40%
ITUB 4.95 -1.79%
AMC 12.76 -1.09%
RPAI 13.15 -3.17%
TGT 161.61 -24.93%
AFI 0.43 43.33%
 
NYSE USA Top Gainers Stocks
MOTV 18.70 50.20%
AFI 0.43 43.33%
AFI 0.43 43.33%
AFI 0.43 43.33%
SPAQ 9.20 42.41%
SPAQ 9.20 42.41%
MTEST 25.01 25.05%
STG 4.80 21.83%
STG 4.80 21.83%
STG 4.80 21.83%
 
NYSE USA Top Losers Stocks
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
PSTH-WS 1.25 -93.65%
PDOT-WS 0.62 -93.65%
CLAA-WS 0.75 -92.26%
 
 
ZYME
Daily Charts
ZYME
Intraday Charts
Whats New @
Bazaartrend
ZYME
Free Analysis
 
ZYME Important Levels Intraday
RESISTANCE6.60
RESISTANCE6.14
RESISTANCE5.86
RESISTANCE5.57
SUPPORT4.77
SUPPORT4.48
SUPPORT4.20
SUPPORT3.74
 
ZYME Target for Month May
4th UP TARGET56.29
3rd UP TARGET39.9
2nd UP TARGET29.76
1st UP TARGET19.63
1st DOWN TARGET-9.29
2nd DOWN TARGET-19.42
3rd DOWN TARGET-29.56
4th DOWN TARGET-45.95
 
ZYME Weekly Target
4th UP TARGET16.21
3rd UP TARGET12.67
2nd UP TARGET10.48
1st UP TARGET8.29
1st DOWN TARGET2.05
2nd DOWN TARGET-0.14
3rd DOWN TARGET-2.33
4th DOWN TARGET-5.87
 
ZYME Target for Year 2022
4th UP TARGET110.13
3rd UP TARGET76.47
2nd UP TARGET55.66
1st UP TARGET34.86
1st DOWN TARGET-24.52
2nd DOWN TARGET-45.32
3rd DOWN TARGET-66.13
4th DOWN TARGET-99.79
 
 
ZYME Other Details
Segment EQ
Market Capital 1054913664.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZYME Address
ZYME
 
ZYME Latest News
 
Your Comments and Response on Zymeworks Inc
 
ZYME Business Profile
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada. Address: 1385 West 8th Avenue, Vancouver, BC, Canada, V6H 3V9
 
ę 2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service